All Stories

  1. 4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy

    Article • Radiotherapy and Oncology, October 2020, Elsevier

    VALERIO NARDONE

  2. Neck emphysema in a HNSCC cancer patient undergoing concurrent radiotherapy and cetuximab

    Article • Reports of Practical Oncology & Radiotherapy, May 2020, Elsevier

    VALERIO NARDONE

  3. Delta-radiomics increases multicentre reproducibility: a phantom study

    Article • Medical Oncology, March 2020, Springer Science + Business Media

    VALERIO NARDONE

  4. GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

    Article • Frontiers in Oncology, November 2019, Frontiers

    VALERIO NARDONE

  5. Lumbosacral Plexopathy in Pelvic Radiotherapy: An Association not to be Neglected; A Systematic Review

    Article • Archives of Neuroscience, September 2019, Kowsar Medical Institute

    VALERIO NARDONE

  6. Delayed enhancement in differential diagnosis of salivary gland neoplasm

    Article • Gland Surgery, September 2019, AME Publishing Company

    VALERIO NARDONE

  7. Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses?

    Article • Gland Surgery, September 2019, AME Publishing Company

    VALERIO NARDONE

  8. Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?

    Article • Clinical Neurology and Neurosurgery, September 2019, Elsevier

    VALERIO NARDONE

  9. The Optimal Choice of Local Therapy for Stage IIIA-N2 NSCLC: Is Radiotherapy Inferior to Surgery?

    Article • The Annals of Thoracic Surgery, September 2019, Elsevier

    VALERIO NARDONE

  10. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases

    Article • Strahlentherapie und Onkologie, May 2019, Springer Science + Business Media

    VALERIO NARDONE

  11. Early blood rise in auto‑antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic‑non‑small cell lung cancer patients treated with PD‑1 immune‑check point blockade by nivolumab

    Article • Molecular and Clinical Oncology, May 2019, Spandidos Publications

    VALERIO NARDONE

  12. Putative Role of Circulating Human Papillomavirus DNA in the Development of Primary Squamous Cell Carcinoma of the Middle Rectum: A Case Report

    Article • Frontiers in Oncology, February 2019, Frontiers

    VALERIO NARDONE

  13. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance

    Article • Journal of Cancer Research and Clinical Oncology, January 2019, Springer Science + Business Media

    VALERIO NARDONE

  14. Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation

    Article • Gastroenterology Research and Practice, January 2019, Hindawi Publishing Corporation

    salvatore cappabianca, VALERIO NARDONE, FERNANDO SCALA

  15. How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies

    Article • Frontiers in Immunology, December 2018, Frontiers

    VALERIO NARDONE

  16. Effects of CT FOV displacement and acquisition parameters variation on texture analysis features

    Article • Physics in Medicine and Biology, December 2018, Institute of Physics Publishing

    VALERIO NARDONE

  17. Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma

    Article • Indian Journal of Gynecologic Oncology, November 2018, Springer Science + Business Media

    VALERIO NARDONE

  18. Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature?

    Article • Radiotherapy and Oncology, October 2018, Elsevier

    VALERIO NARDONE

  19. The role of delta radiomics in gastric cancer

    Article • Quantitative Imaging in Medicine and Surgery, August 2018, AME Publishing Company

    VALERIO NARDONE

  20. Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer

    Article • Medicine, May 2018, Wolters Kluwer Health

    VALERIO NARDONE

  21. Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine

    Article • Oncotarget, April 2018, Impact Journals, LLC

    VALERIO NARDONE

  22. The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer

    Article • Expert Review of Anticancer Therapy, March 2018, Taylor & Francis

    VALERIO NARDONE

  23. 3D bone texture analysis as a potential predictor of radiation-induced insufficiency fractures

    Article • Quantitative Imaging in Medicine and Surgery, February 2018, AME Publishing Company

    VALERIO NARDONE

  24. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT

    Article • La radiologia medica, January 2018, Springer Science + Business Media

    VALERIO NARDONE

  25. Epidermal Growth Factor Receptor Expression Predicts Time and Patterns of Recurrence in Patients with Glioblastoma After Radiotherapy and Temozolomide

    Article • World Neurosurgery, January 2018, Elsevier

    VALERIO NARDONE

  26. Volumetric texture analysis in the characterisation of interstitial lung diseases in lung transplant patients

    Article • September 2017, European Respiratory Society (ERS)

    VALERIO NARDONE

  27. Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients

    Article • Journal of Thoracic Disease, September 2017, AME Publishing Company

    VALERIO NARDONE

  28. Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)

    Article • Oncotarget, August 2017, Impact Journals, LLC

    VALERIO NARDONE

  29. Is there a potential role for EGFR expression to lead margin reduction in glioblastoma?

    Article • Journal of Neuro-Oncology, April 2017, Springer Science + Business Media

    VALERIO NARDONE

  30. Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS)

    Article • Neurological Sciences, March 2017, Springer Science + Business Media

    VALERIO NARDONE

  31. Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures

    Article • Osteoporosis International, February 2017, Springer Science + Business Media

    VALERIO NARDONE

  32. Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis

    Article • Radiotherapy and Oncology, February 2017, Elsevier

    VALERIO NARDONE

  33. Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    VALERIO NARDONE

  34. In Regard to Kubicek et al

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2016, Elsevier

    VALERIO NARDONE

  35. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse

    Article • Cancer Biology & Therapy, October 2016, Taylor & Francis

    GAETANO FACCHINI, VALERIO NARDONE

  36. The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma

    Article • Clinical Neurology and Neurosurgery, October 2016, Elsevier

    VALERIO NARDONE

  37. Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk

    Article • Radiotherapy and Oncology, July 2016, Elsevier

    VALERIO NARDONE

  38. Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect?

    Article • Acta Neurologica Belgica, June 2016, Springer Science + Business Media

    VALERIO NARDONE

  39. Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    VALERIO NARDONE